Therapeutics of Viral Hepatitis Flashcards
Signs and Symptoms of Acute Hepatitis
May be asymptomatic Flu-like Skin rash Jaundice Light colored stool Dark urin
Signs and symptoms of Chronic Hepatitis
Infections present for more than 6 months
Asymptomatic
Malase or fatigue
Can progress to cirrhosis (liver failure)
At risk for liver cancer
HAV
It is preventable and you rarely see it any more
HBsAg
Hep B Surface antigen
Persistence for greater than 6 months = chronic infection
DO YOU HAVE THE VIRUS?
HBeAg
Indicates active replicating virus
IS IT ACTIVE?
HBV DNA
Actual level of virus
HOW MUCH OF THE VIRUS DO YOU HAVE?
Antigens vs Antibodies
Antigens are produced by the virus and antibodies are produced by your body
Anti-HBS or HBsAb
Antibody to hepatitis B surface antigen
Have it because you had it and recovered and have immunity OR you were vaccinated
AntiHBc or HBcAb
Antibody to hepatitis B core antigen
Previous or ongoing infection
Occurs at the onset of infection and last for life
Anti-HBe or HBeAb
Antibody to Hep Be antigen
Lower level of viral replication
- NO REPLICATION
Seroconversion
Has a positive antigen (replication) and now have positive antibody (no replication
HBsAB (-) + HBsAG (-)
Patient needs vaccination but doesnt have HBV
HBsAb (+) + HBsAg (-)
Patient is immune either through vaccine or previously cleared infection
No active disease
HBsAb (-) + HBsAg (+)
Patient has HBV and if this has been positive for more than 6 months then it is chronic HBV
Hep A Vaccine Schedule
Month 0 and month 6
Hep B Vaccine Schedule
Month 0, month 1, and month 7
HBV Post Exposure
Give both Immune globulin + HBV seizures
Chronic Hepatitis B
HBsAg positive for more than 6 months
Goals of Hep B Treatment
Viral suppression (undetectable HBV DNA)
Seroconversion (positive eAg to positive eAb)
Loss of HBsAg
Prevent cirrhosis, hepatic failure and HCC
Elevated HBV DNA Levels
HBeAg(+) + Greater than or equal to 20,000 or 10^5 copies/mL
HBeAg(-) + Greater than or equal to 2000 or 10^4 copies/mL
When to treat?
Elevated HBV DNA levels + Elevated ALT more than 2 times ULN (30 in men, 19 in women) OR moderate/advance liver disease on biopsy
1st Line Treatment Options
Tenofovir, entecavir or peginterferon (SC weekly)
Chronic Treatment Duration
48 weeks with either PegIFN or nucleotide analogs (PO)
Discontinue antiviral therapy
HBsAg loss or HBeAg seroconversion on 2 separate at least 6-12 months apart